208 related articles for article (PubMed ID: 16838326)
1. A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high-dose cytarabine.
Billio A; Svaldi M; Morello E; Amato B; Coser P
Am J Hematol; 2006 Oct; 81(10):798-9. PubMed ID: 16838326
[No Abstract] [Full Text] [Related]
2. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
[TBL] [Abstract][Full Text] [Related]
3. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
Fujishima N; Fujishima M; Inomata M; Yamanaka Y; Saitoh K; Kameoka Y; Yoshioka T; Saitoh H; Takahashi N; Hirokawa M; Sawada K
Rinsho Ketsueki; 2007 Apr; 48(4):326-31. PubMed ID: 17515125
[TBL] [Abstract][Full Text] [Related]
4. Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.
Li Y; Huang S; Wang X; Zhou D; Huang K; Guo H; Fang J; Chen C; Liu Q
J Trop Pediatr; 2010 Oct; 56(5):337-41. PubMed ID: 20065046
[TBL] [Abstract][Full Text] [Related]
5. Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia.
Griskevicius L; Stulpinas R; Vengalyte I; Saulyte-Trakymiene S; Mickys U; Pranys D; Kurtinaitis J; Jurgutis M
Leuk Res; 2009 Apr; 33(4):587-8. PubMed ID: 18762337
[No Abstract] [Full Text] [Related]
6. [Efficacy of modified B-NHL-BFM-90 protocol on Burkitt's lymphoma in Chinese children and adolescents].
Sun XF; Zhen ZJ; Liu DG; Xia Y; Xiang XJ; Chen XQ; Ling JY; Zheng L; Luo WB; Lin H; He YJ; Guan ZZ
Ai Zheng; 2007 Dec; 26(12):1339-43. PubMed ID: 18076797
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Mey UJ; Orlopp KS; Flieger D; Strehl JW; Ho AD; Hensel M; Bopp C; Gorschlüter M; Wilhelm M; Birkmann J; Kaiser U; Neubauer A; Florschütz A; Rabe C; Hahn C; Glasmacher AG; Schmidt-Wolf IG
Cancer Invest; 2006 Oct; 24(6):593-600. PubMed ID: 16982464
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
9. Burkitt's lymphoma in a 45-year-old Nigerian woman.
Lawal OO; Ojo OS; Durosinmi MA
Trop Geogr Med; 1990 Jul; 42(3):294-7. PubMed ID: 2293442
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in a child with relapsed Burkitt lymphoma.
Bay A; Dogan M; Acikgoz M; Oner AF
Pediatr Blood Cancer; 2007 Aug; 49(2):218. PubMed ID: 16847929
[No Abstract] [Full Text] [Related]
11. Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab.
Goldaniga M; Guffanti A; Gianelli U; Magni M; Lambertenghi Deliliers G; Baldini L
Haematologica; 2004 Nov; 89(11):ECR41. PubMed ID: 15533846
[No Abstract] [Full Text] [Related]
12. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
Shah GD; Yahalom J; Correa DD; Lai RK; Raizer JJ; Schiff D; LaRocca R; Grant B; DeAngelis LM; Abrey LE
J Clin Oncol; 2007 Oct; 25(30):4730-5. PubMed ID: 17947720
[TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.
Oriol A; Ribera JM; Bergua J; Giménez Mesa E; Grande C; Esteve J; Brunet S; Moreno MJ; Escoda L; Hernandez-Rivas JM; Hoelzer D
Cancer; 2008 Jul; 113(1):117-25. PubMed ID: 18457327
[TBL] [Abstract][Full Text] [Related]
14. Refractoriness to rituximab monotherapy in a child with relapsed/refractory Burkitt non-Hodgkin lymphoma.
Okur FV; Oguz A; Karadeniz C; Citak C; Poyraz A; Boyunaga O
Pediatr Hematol Oncol; 2006; 23(1):25-31. PubMed ID: 16326409
[TBL] [Abstract][Full Text] [Related]
15. Conventional dose intensive immunochemotherapy regimen in an adult patient with very late relapse of Burkitt's lymphoma.
Italiano A; Peyrade F; Soler C; Cardot N; Thyss A
J Chemother; 2007 Apr; 19(2):236-8. PubMed ID: 17434838
[No Abstract] [Full Text] [Related]
16. [Burkitt's lymphoma in HIV-infected patients].
Kath R; Günzel K; Höffken K; Schmidt CG; Donhuijsen K
Dtsch Med Wochenschr; 1990 Aug; 115(34):1293-4. PubMed ID: 2390943
[No Abstract] [Full Text] [Related]
17. Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: final results of a phase 2 study (Burkimab).
Ribera JM; García O; Grande C; Esteve J; Oriol A; Bergua J; González-Campos J; Vall-Llovera F; Tormo M; Hernández-Rivas JM; García D; Brunet S; Alonso N; Barba P; Miralles P; Llorente A; Montesinos P; Moreno MJ; Hernández-Rivas JÁ; Bernal T
Cancer; 2013 May; 119(9):1660-8. PubMed ID: 23361927
[TBL] [Abstract][Full Text] [Related]
18. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Burkitt's lymphoma during pregnancy.
Lam MS
Ann Pharmacother; 2006 Nov; 40(11):2048-52. PubMed ID: 17062832
[TBL] [Abstract][Full Text] [Related]
20. Durable remission induced by rituximab-containing chemotherapy in a patient with primary refractory Burkitt's lymphoma.
Yokohama A; Tsukamoto N; Uchiumi H; Handa H; Matsushima T; Karasawa M; Murakami H; Nojima Y
Ann Hematol; 2004 Feb; 83(2):120-3. PubMed ID: 14513289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
